Boxed meds interactions

A box drawn around a mascot means the medication is largely free of clinically relevant kinetic drug interactions — but not entirely.

There is a deliberate hole at the top of each box. It says that some kinetic interaction may still occur, just not to a degree a prescriber needs to plan around. In most cases the area under the curve of a co-prescribed victim drug is unchanged.

A box may also carry an asterisk element — hair poking out over the rim, for instance — marking a specific, named exception to an otherwise low-interaction profile.

Most boxed medications earn the box the same way: they are cleared renally rather than metabolically, so they never depend on CYP capacity and nothing that induces or inhibits an enzyme can move them. The lisinopril and valsartan families, the thiazide and loop diuretics, the gliflozins, the insulins, the NSAIDs and the beta-blockers atenolol and nadolol are all here for that reason.

The box is a claim about kinetics only. Dynamic interactions are untouched by it: two boxed drugs can still add their effects on blood pressure, QT interval, sedation, bleeding, electrolytes or serotonergic load. For older drugs the box sometimes reflects an absence of studies rather than an absence of effect.